Sizhe Wan

436 total citations
18 papers, 279 citations indexed

About

Sizhe Wan is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Sizhe Wan has authored 18 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Sizhe Wan's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (5 papers) and Liver physiology and pathology (3 papers). Sizhe Wan is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (5 papers) and Liver physiology and pathology (3 papers). Sizhe Wan collaborates with scholars based in China. Sizhe Wan's co-authors include Xuan Zhu, Chenkai Huang, Anjiang Wang, Bin Wu, Mingkai Li, Yiming Lei, Bimin Li, Yuan Nie, Yue Zhang and Jiang Chen and has published in prestigious journals such as Cell Death and Disease, Frontiers in Pharmacology and Frontiers in Physiology.

In The Last Decade

Sizhe Wan

18 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sizhe Wan China 10 124 122 107 43 37 18 279
Xingliang Zhao China 8 134 1.1× 106 0.9× 77 0.7× 27 0.6× 43 1.2× 17 324
Baoyu Liang China 7 118 1.0× 90 0.7× 62 0.6× 32 0.7× 45 1.2× 10 276
Weiguang Ren China 10 124 1.0× 153 1.3× 92 0.9× 31 0.7× 52 1.4× 24 333
Amr El-Karef Egypt 11 111 0.9× 95 0.8× 59 0.6× 37 0.9× 28 0.8× 19 368
Jin‐Zhong Dong China 8 152 1.2× 130 1.1× 108 1.0× 37 0.9× 86 2.3× 13 354
Mao‐xu Ge China 11 133 1.1× 157 1.3× 123 1.1× 58 1.3× 26 0.7× 15 357
Liuying Chen China 10 127 1.0× 140 1.1× 87 0.8× 23 0.5× 38 1.0× 17 324
Facheng Bai China 10 93 0.8× 138 1.1× 101 0.9× 41 1.0× 23 0.6× 14 268
Dewen Mao China 9 73 0.6× 78 0.6× 65 0.6× 40 0.9× 22 0.6× 31 207
Amal M. H. Ghanim Egypt 10 122 1.0× 60 0.5× 45 0.4× 41 1.0× 24 0.6× 12 316

Countries citing papers authored by Sizhe Wan

Since Specialization
Citations

This map shows the geographic impact of Sizhe Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sizhe Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sizhe Wan more than expected).

Fields of papers citing papers by Sizhe Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sizhe Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sizhe Wan. The network helps show where Sizhe Wan may publish in the future.

Co-authorship network of co-authors of Sizhe Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Sizhe Wan. A scholar is included among the top collaborators of Sizhe Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sizhe Wan. Sizhe Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Li, Mingkai, et al.. (2024). The fibrosis investigating navigator in diabetes ( FIND ): A tool to predict liver fibrosis risk in subjects with diabetes. Diabetes Obesity and Metabolism. 27(3). 1184–1197. 3 indexed citations
3.
Wan, Sizhe, et al.. (2024). Activated hepatic stellate cell-derived Bmp-1 induces liver fibrosis via mediating hepatocyte epithelial-mesenchymal transition. Cell Death and Disease. 15(1). 41–41. 11 indexed citations
4.
Wan, Sizhe, Yujun Luo, Huiling Liu, et al.. (2022). Hepatitis B virus X protein induces ALDH2 ubiquitin-dependent degradation to enhance alcoholic steatohepatitis. Gastroenterology report. 11. goad006–goad006. 6 indexed citations
5.
Li, Mingkai, Sizhe Wan, Xiaoying Wu, Ying Lin, & Bin Wu. (2022). Diagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysis. Gastroenterology report. 10(1). goac005–goac005. 5 indexed citations
6.
Wan, Sizhe, Yiming Lei, Mingkai Li, & Bin Wu. (2021). A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes. Hepatology International. 16(1). 112–124. 38 indexed citations
7.
Lei, Yiming, Sizhe Wan, Huiling Liu, et al.. (2021). ARRB1 suppresses the activation of hepatic macrophages via modulating endoplasmic reticulum stress in lipopolysaccharide-induced acute liver injury. Cell Death Discovery. 7(1). 223–223. 6 indexed citations
9.
Wan, Sizhe, Yuan Nie, Yue Zhang, Chenkai Huang, & Xuan Zhu. (2020). Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice. Frontiers in Cellular and Infection Microbiology. 10. 18–18. 17 indexed citations
10.
Wan, Sizhe, Yuan Nie, & Xuan Zhu. (2020). Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma. PeerJ. 8. e8497–e8497. 8 indexed citations
11.
Nie, Yuan, et al.. (2020). Serum Urea Predicts Long-term Mortality in Hospitalized Patients with Decompensated Cirrhosis. Hepatitis Monthly. 20(4). 1 indexed citations
12.
Wan, Sizhe, et al.. (2020). Effectiveness and safety of endoscopic treatment for duodenal variceal bleeding: a systematic review. European Journal of Gastroenterology & Hepatology. 33(4). 461–469. 11 indexed citations
13.
Wan, Sizhe, et al.. (2020). Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways. Aging. 12(11). 10614–10632. 31 indexed citations
14.
Wan, Sizhe, Chenkai Huang, Anjiang Wang, & Xuan Zhu. (2020). Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice. PeerJ. 8. e9050–e9050. 14 indexed citations
15.
Wan, Sizhe, Chenkai Huang, & Xuan Zhu. (2019). Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients. BMJ Open. 9(7). e030038–e030038. 13 indexed citations
16.
Zhang, Wang, Jie Jian, Chenkai Huang, et al.. (2019). Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis. Frontiers in Physiology. 10. 956–956. 29 indexed citations
17.
Wan, Sizhe, et al.. (2019). Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice. Frontiers in Pharmacology. 10. 1321–1321. 50 indexed citations
18.
Huang, Chenkai, Sizhe Wan, Jiang Chen, et al.. (2019). Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells. Frontiers in Pharmacology. 10. 431–431. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026